FDA Clearance Tracker · K252728
IDS-iSYS Total Testosterone
Last checked: Nov 20, 2026Latest source record: Apr 15, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Apr 15, 2026
Substantially Equivalent
Time to decision
230 days
Received Aug 28, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class I
The decision
- FDA number
- K252728
- Device name
- IDS-iSYS Total Testosterone
- Applicant
- Immunodiagnostic Systems Limited
- Applicant location
- Tyne & Wear, GB
- Received
- Aug 28, 2025
- Decided
- Apr 15, 2026
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class I
- Regulation
- 21 CFR 862.1680
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code CDZ. The earliest in FDA's data is K772191, decided Jan 12, 1978.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K252728
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Immunodiagnostic Systems Limited
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K240865 · Decided Oct 23, 2024 · 209 days after receipt
Device type: Radioimmunoassay, Testosterones And Dihydrotestosterone (CDZ) · Laboratory Medicine & Pathology
- IDS ACTH II510(k)
K223867 · Decided Aug 18, 2023 · 238 days after receipt
Device type: Radioimmunoassay, Acth (CKG) · Laboratory Medicine & Pathology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.